UPDATE 1-Fresenius Medical Care names new CEO as of Jan. 1 [Reuters]
FRESENIUS SE S/ADR (FSNUY)
NASDAQ:AMEX Investor Relations:
fresenius.com/index
Company Research
Source: Reuters
Powell's retirement will come after 10 years at the company's helm and is in line with the company's policies on age limits. FMC said Kriwet was most recently CEO of BSH Hausgeraete GmbH. FMC has been cutting costs and up to 5,000 jobs globally - or about 4% of its workforce - because of a high death toll among its dialysis patients, who are more vulnerable to the coronavirus. The world's largest provider of dialysis treatments aims to reach annual cost cuts of 500 million euros by 2025, as it plans to replace its four regions and some global functions with two divisions: care enablement and care delivery. Stephan Sturm, CEO of parent company Fresenius SE, in February left the door open for a future divestment of separately listed dialysis unit FMC, even after FMC forecast a return to earnings growth this year. (Reporting by Ludwig Burger; Additional reporting by Tom Sims; Editing by Chris Reese)
Show less
Read more
Impact Snapshot
Event Time:
FSNUY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
FSNUY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
FSNUY alerts
High impacting FRESENIUS SE S/ADR news events
Weekly update
A roundup of the hottest topics
FSNUY
News
- Fresenius Accelerates Momentum in its (Bio)Pharma Business and Launches Tyenne®, its Third Approved Biosimilar in the U.S.Business Wire
- Fresenius Kabi Further Expands Oncology Portfolio with Launch of Cyclophosphamide for Injection, USP [Yahoo! Finance]Yahoo! Finance
- Fresenius Targets Faster Earnings Growth After More Cost Cuts [BNN Bloomberg (Canada)]BNN Bloomberg
- Fresenius Kabi Launches Posaconazole Injection for Prevention or Treatment of Fungal Infections [Yahoo! Finance]Yahoo! Finance
- Membrane Oxygenators Market Projected to Surpass US$ 166 million by 2032, Showing a 1.9% CAGR, Persistence Market Research [Yahoo! Finance]Yahoo! Finance